Vitry-en-Artois, France

Andr E Tartar

This inventor holds 1 USPTO granted patent. Top assignees: Institut Pasteur, Institut Pasteur De Lille, National Institute of Health and Medical Research. Active years: 1996.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Andr E Tartar: Innovator in Diagnostic Peptide Sequences

Introduction

Andr E Tartar is a notable inventor based in Vitry-en-Artois, France. He has made significant contributions to the field of diagnostics, particularly through his work on antigenic peptide sequences. His innovative approach has led to advancements in the understanding and diagnosis of diseases caused by echinococcus granulosus.

Latest Patents

Andr E Tartar holds a patent for an antigenic peptide sequence of echinococcus granulosus and its diagnostic applications. This patent represents a crucial step in the development of diagnostic tools that can improve disease detection and management. He has 1 patent to his name, showcasing his focused contributions to the field.

Career Highlights

Throughout his career, Tartar has worked with prestigious institutions such as Institut Pasteur and Institut Pasteur de Lille. His experience in these renowned organizations has allowed him to collaborate with leading experts in the field of biomedical research. His work has been instrumental in advancing the understanding of various diseases.

Collaborations

Andr E Tartar has collaborated with notable colleagues, including Brigitte Facon and Mustapha Chamekh. These partnerships have enriched his research and contributed to the successful development of his patented innovations.

Conclusion

Andr E Tartar's contributions to the field of diagnostics through his innovative work on peptide sequences highlight his role as a significant inventor. His patent and collaborations reflect his commitment to advancing medical science and improving diagnostic methods.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…